Duke Institute of Cancer/ Duke University — Durham, North Carolina

Duke Institute of Cancer/ Duke University is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Institute of Cancer/ Duke University has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Multiple Myeloma.

Sponsors: Karyopharm Therapeutics Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Institute of Cancer/ Duke University?

Duke Institute of Cancer/ Duke University has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Institute of Cancer/ Duke University conducted?

Duke Institute of Cancer/ Duke University has 1 clinical trials on record, with 1 currently active. Their work covers Multiple Myeloma.

Is Duke Institute of Cancer/ Duke University accredited by Crixeo Health?

Duke Institute of Cancer/ Duke University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Institute of Cancer/ Duke University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.